CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,050 enrolled
Drug / intervention
Laparoscopic gastrectomy +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01456598
NCT01456598N/ACompleted

Prospective Multicenter Randomized Controlled Clinical Trial for Comparison Between Laparoscopic and Open Subtotal Gastrectomy With D2 Lymph Node Dissection for Locally Advanced Gastric Cancer

Ajou University School of Medicine·interventional·Posted Oct 21, 2011·Updated Nov 29, 2018

In Brief

A clinical study evaluating Laparoscopic gastrectomy and Open gastrectomy for Gastric Cancer. Completed, enrolled 1,050 participants across 13 sites.

Detailed Summary

* It was confirmed that the laparoscopic surgery decreases the postoperative pain and reduces the recovery periods in the various surgical fields such as cholecystectomy and colectomy etc. Also, there are clinical evidences that the laparoscopic surgery is applicable to malignant tumor according to the development of surgical techniques and medical instruments. * In case of early stage of gastric cancer, as the diverse clinical evidences, the gastrectomy has been commonly applied, however, the opening surgery is still applied for advanced gastric cancer due to lack of clinical evidence. * In Korea, approximately 38% of patients who undergo surgery for gastric cancer are diagnosed by T2-T3 (AJCC 6th edition) (www.i-kgca.or.kr, National gastric cancer registration business in 2009). There are various clinical evidences to apply laparoscopic surgery to the patients, however, most of them are retrospective or cohort study results. * For the clinical application of surgical treatment regarding locally advanced gastric cancer using laparoscopic surgical technique, it requires the confirmation of definite execution for laparoscopic gastrectomy and D2 lymph node dissection and the safety of surgery and oncological usefulness should be verified. * In order for this, it is only possible to confirm through the comparison of short-term surgical results (complications, mortalities, operative time and duration of hospitalization etc) and long-term results (survival rates and recurrence rates etc) between laparoscopic surgery and opening surgery based on the multicenter large-sized randomized prospective study with current standard treatment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGastric Cancer
CountriesSouth Korea
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedOct 21, 2011
Enrollment StartNov 21, 2011
Primary CompletionJun 2, 2018
TodayJul 2, 2026
Enrollment to primary: 6.5 yearsPosted 14.7 years ago

Interventions

Laparoscopic gastrectomyprocedure

* After laparoscopic observation, the possibility of surgery can be considered by examining inside of abdomen. * The surgeon undergoes laparoscopic subtotal gastrectomy and D2 lymph node dissection * After lymph node dissection, it is possible to undergo gastrectomy on appropriate part and reconstruction under small incision or laparoscopic view. * As the reconstruction, one of the techniques like Billroth I, Billroth II and Roux en Y and so on is applied and there is no limitation on use of appliance.

Open gastrectomyprocedure

* After laparotomy, the possibility of surgery can be considered by examining inside of abdomen. * The surgeon undergoes open subtotal gastrectomy and D2 lymph node dissection * After lymph node dissection, one of the techniques likes Billroth I, Billroth II and Roux en Y and so on is applied and there is no limitation on use of appliance.